Exogenous IL-27 Prevents the Development of Alopecia Areata

This study investigates the therapeutic potential of IL-27 in preventing alopecia areata (AA), an autoimmune disease characterized by hair loss. Using a skin-graft induction model in mice, researchers employed an adeno-associated virus to overexpress IL-27 (AAV-IL27). The results showed that mice treated with AAV-IL27 were fully protected from developing AA, with minimal CD8 T cell infiltration into hair follicles and an increase in IL-10 producing CD4 T cells. This suggests that IL-27 may prevent AA by promoting immunosuppressive T cells. However, treated mice also developed a population of NKG2D expressing CD8 T cells, typically associated with disease presence. Further research is needed to clarify IL-27's mechanisms and its potential as an AA treatment.